Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Crowe

Showing results (51-60 of 316) with videos related to

Pageof 32
Sort By:
Neoplasia (New York, N.Y.)|August 10, 2000
Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasionD L Crowe, T N Brown
Biochimica Et Biophysica Acta|March 27, 2001
Rb and E2F-1 regulate telomerase activity in human cancer cellsD L Crowe, D C Nguyen
Australasian Radiology|November 1, 1991
Cost considerations in the provision of magnetic resonance imaging servicesD M Hailey, B L Crowe
Langmuir : the ACS Journal of Surfaces and Colloids|July 12, 2008
Silica passivation efficiency monitored by a surface-bound fluorescent dyeLoretta L Crowe, Laren M Tolbert
BMC Cancer|November 18, 2010
Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligandsJi Seung Han, David L Crowe
The Journal of Endocrinology|April 3, 2007
Coactivator-mediated estrogen response in human squamous cell carcinoma linesTony K S Ku, David L Crowe
Molecular Medicine Reports|April 12, 2011
Genomic profiling of decreased DNA damage response in human squamous carcinoma cellsTony K S Ku, David L Crowe
Oncogene|December 22, 2015
Tumor suppressor control of the cancer stem cell nicheK Kramer, J Wu, D L Crowe
Development and Psychopathology|October 8, 2008
The development of antisocial behavior: what can we learn from functional neuroimaging studies?S L Crowe, R J R Blair
Breast Cancer Research : BCR|August 21, 2004
A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligandsDavid L Crowe, Roshantha A S Chandraratna
Pageof 32

Showing results (51-60 of 316) with videos related to

Sort By:
Pageof 32
Neoplasia (New York, N.Y.)|August 10, 2000
Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasionD L Crowe, T N Brown
Biochimica Et Biophysica Acta|March 27, 2001
Rb and E2F-1 regulate telomerase activity in human cancer cellsD L Crowe, D C Nguyen
Australasian Radiology|November 1, 1991
Cost considerations in the provision of magnetic resonance imaging servicesD M Hailey, B L Crowe
Langmuir : the ACS Journal of Surfaces and Colloids|July 12, 2008
Silica passivation efficiency monitored by a surface-bound fluorescent dyeLoretta L Crowe, Laren M Tolbert
BMC Cancer|November 18, 2010
Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligandsJi Seung Han, David L Crowe
The Journal of Endocrinology|April 3, 2007
Coactivator-mediated estrogen response in human squamous cell carcinoma linesTony K S Ku, David L Crowe
Molecular Medicine Reports|April 12, 2011
Genomic profiling of decreased DNA damage response in human squamous carcinoma cellsTony K S Ku, David L Crowe
Oncogene|December 22, 2015
Tumor suppressor control of the cancer stem cell nicheK Kramer, J Wu, D L Crowe
Development and Psychopathology|October 8, 2008
The development of antisocial behavior: what can we learn from functional neuroimaging studies?S L Crowe, R J R Blair
Breast Cancer Research : BCR|August 21, 2004
A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligandsDavid L Crowe, Roshantha A S Chandraratna
Pageof 32